← Back

Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science (RC2 Clinical Trials Optional)

This grant supports the development and demonstration of unique hub capabilities, research platforms, or resources that address critical gaps or roadblocks in clinical and translational science at awarded UM1 CTSA Program Hubs. The program aims to create foundations for future adoption and dissemination of these capabilities to additional CTSA hubs.

Amount
Not stated
Type
Grant

Key facts

Key facts for Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science (RC2 Clinical Trials Optional)
AmountNot stated
IssuerNational Institutes of Health
Who can applyUniversities
SectorsHealthTech
DeadlineClosed 28 Sep 2026

Unlock application details

See all eligibility criteria, required documents and the official application link. Free account, no card.

Update history

Source: grants.gov ↗

Source checked 40 days ago

  1. 91 days agoagentImported from the official source